Showing results (221-230 of 366) with videos related to
Sort By:
Pageof 37
Molecular Cancer Therapeutics|October 22, 2016
The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma CellsTeresa Delgado-Goni, Maria Falck Miniotis, Slawomir Wantuch, et al.Cancer Journal (Sudbury, Mass.)|October 15, 2009
Biomarker-driven early clinical trials in oncology: a paradigm shift in drug developmentDaniel S W Tan, George V Thomas, Michelle D Garrett, et al.The Annals of Pharmacotherapy|June 5, 2008
Effects of cerivastatin withdrawal on statin persistenceKristen T Reaume, Steven R Erickson, Michael P Dorsch, et al.Journal of Biomolecular Screening|December 20, 2005
Identification of inhibitors of the kinase activity of oncogenic V600E BRAF in an enzyme cascade high-throughput screenYvette Newbatt, Samantha Burns, Robert Hayward, et al.Cancer Letters|July 27, 2013
Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stressLei Zhang, Jacqueline J L Fok, Fabio Mirabella, et al.Clinical Colorectal Cancer|May 26, 2011
Correlation of overall survival with gene expression profiles in a prospective study of resectable esophageal cancerSheela Rao, Lyndsey Welsh, David Cunningham, et al.Cancer Biology & Therapy|March 13, 2012
Sensitization of (colon) cancer cells to death receptor related therapies: a report from the FP6-ONCODEATH research consortiumAlexander Pintzas, Boris Zhivotovsky, Paul Workman, et al.Analytical Biochemistry|August 5, 2003
High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cellsS Elaine Barrie, Ebun Eno-Amooquaye, Anthea Hardcastle, et al.The Journal of Pathology|February 7, 2009
Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neckSusanne J Rogers, Carol Box, Philip Chambers, et al.Bioorganic & Medicinal Chemistry|July 14, 2006
Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo, et al.Pageof 37